The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online

📢It’s #WorldCancerResearchDay!

➡️Head over to http://VJOncology.com to explore exciting updates in the latest clinical trials!

⭐Whilst you’re there, make sure to check out some of the cutting-edge research presented at #ESMO22 just last week!

@myESMO @VJOncology

📢http://VJOncology.com has roundtable discussions featuring leading experts of #LungCancer, #BreastCancer, and more!

⭐Listen as they discuss key issues in cancer research in light of #WorldCancerResearchDay

➡️http://ow.ly/ixbX50KQh5s⬅️

#Oncology #VJSession @VJOncology

🎥 @david_tougeron of Poitiers University Hospital discusses DURIGAST: 2L FOLFIRI plus durvalumab plus tremelimumab in gastric or GEJ cancer

Watch: 👉http://ow.ly/RBmH50KQzCP👈

@myESMO #ESMO22

📢Check out some of the highlights from ASCO 2022 over at http://VJOncology.com, including key updates in clinical trials generating improved outcomes for patients worldwide.

📖Read here ➡️http://ow.ly/PO4s50KQgfE⬅️

#WorldCancerResearchDay @ASCO @VJOncology #ASCO22 #Oncology

We’re here to bring you the highlights of what experts have been discussing on the second day of #NACLC22! 🙌

Check out http://VJOncology.com to discover more about what experts have discussed so far in the field of #LungCancer.

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online
The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

📢It’s #WorldCancerResearchDay!

➡️Head over to http://VJOncology.com to explore exciting updates in the latest clinical trials!

⭐Whilst you’re there, make sure to check out some of the cutting-edge research presented at #ESMO22 just last week!

@myESMO @VJOncology

📢http://VJOncology.com has roundtable discussions featuring leading experts of #LungCancer, #BreastCancer, and more!

⭐Listen as they discuss key issues in cancer research in light of #WorldCancerResearchDay

➡️http://ow.ly/ixbX50KQh5s⬅️

#Oncology #VJSession @VJOncology

🎥 @david_tougeron of Poitiers University Hospital discusses DURIGAST: 2L FOLFIRI plus durvalumab plus tremelimumab in gastric or GEJ cancer

Watch: 👉http://ow.ly/RBmH50KQzCP👈

@myESMO #ESMO22

📢Check out some of the highlights from ASCO 2022 over at http://VJOncology.com, including key updates in clinical trials generating improved outcomes for patients worldwide.

📖Read here ➡️http://ow.ly/PO4s50KQgfE⬅️

#WorldCancerResearchDay @ASCO @VJOncology #ASCO22 #Oncology

We’re here to bring you the highlights of what experts have been discussing on the second day of #NACLC22! 🙌

Check out http://VJOncology.com to discover more about what experts have discussed so far in the field of #LungCancer.

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter